An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma
Clinical trial NCT02596035 · COMPLETED
Trial details
- NCT number
- NCT02596035
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-08
- Primary completion
- 2018-03-19
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.